You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Advocates' Perspective: Neoadjuvant Chemotherapy for Breast Cancer
|
|---|---|
| Published in |
Journal of Clinical Oncology, November 2012
|
| DOI | 10.1200/jco.2012.44.1824 |
| Pubmed ID | |
| Authors |
Jane Perlmutter, Susan Axler, Carole Baas, Barbara J. Beckwith, Amy Bonoff, Susan Brain, Maryellen Delapine, Margaret Devine, Elizabeth Frank, Valerie Fraser, Marjorie Gallece, Cindy Geoghegan, Hiam Hamade, Diane Heditsian, Bonnie Hirschhorn, Stephen Kandell, Deborah Laxague, Barbara LeStage, Maria Lyzen, Debra Madden, Shirley A. Mertz, Beverly J. Parker, Nancy Roach, Nancy Sauers, Linda Vincent, Dorothy Waddell, Maria Wetzel, Kimberly Wright |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 13 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 6 | 46% |
| Student > Ph. D. Student | 3 | 23% |
| Researcher | 3 | 23% |
| Student > Master | 1 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 62% |
| Biochemistry, Genetics and Molecular Biology | 2 | 15% |
| Agricultural and Biological Sciences | 1 | 8% |
| Unknown | 2 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2013.
All research outputs
#20,656,161
of 25,373,627 outputs
Outputs from Journal of Clinical Oncology
#20,189
of 22,043 outputs
Outputs of similar age
#226,092
of 285,392 outputs
Outputs of similar age from Journal of Clinical Oncology
#172
of 232 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,043 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,392 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 232 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.